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Optimizing Implementation of  
Universal HIV Treatment Coverage for  
People Living with HIV in Senegal
Senegal plans a rapid scale up of HIV treatment for 
all people living with HIV (PLHIV), regardless of CD4 
count or viral suppression. However, limited data 
exist on how to achieve sustained viral suppression 
among PLHIV in real world contexts where significant 
barriers to effective antiretroviral therapy (ART) 
delivery, uptake, and adherence persist. Such 
information is critical to inform the rollout of 
Senegal’s national test and treat strategy. 
Project SOAR and partners are addressing these 
knowledge gaps by developing and testing a 
universal coverage ART intervention among PLHIV 
who are not virally suppressed.1 Specifically, the 
study aims to: 
	Determine the feasibility, fidelity, and cost-
effectiveness of individual case management 
compared to standard of care (SOC) in achieving 
sustained viral suppression.
	Assess the acceptability of HIV self-testing by 
people at high risk of HIV infection and whether 
the promotion of self-testing increases the number 
of newly diagnosed PLHIV in clinic settings. 
	Assess the acceptability of iris scanning as a 
strategy to enhance the measurement of follow-up 
and retention of PLHIV receiving ART.
The results of this study will inform health care 
policy and practice in Senegal on the use of HIV 
self-testing approaches to increase the number of 
PLHIV diagnosed, case management interventions to 
improve care retention, and iris scanning to support 
measurement of retention in ART programs. Given 
Senegal’s leadership role across West and Central 
Africa, the results are likely to inform implementation 
of test and treat programs across this broad and 
diverse region. 
OUR RESEARCH
This study is an individual-level randomized 
controlled trial that examines the impact of 











Research Partners: Johns Hopkins 
University (JHU); Enda Santé; Division de 
Lutte Contre le SIDA, Ministry of Health (MOH)
Location: Dakar and Ziguinchor
Study Duration: 2015–2019
For more information, contact Stefan Baral, 
Johns Hopkins University, sbaral@jhu.edu.
As part of our research, we are assessing HIV 
self-testing by people at high risk of HIV infection. 
1This study is part of a portfolio of three studies—one each 
in Senegal, Namibia and Nigeria—that SOAR and partners 
are conducting to evaluate strategies to improve treatment 
outcomes among PLHIV reached through test and treat 
approaches. For more information about these studies, visit 
our website: projsoar.org.   
PHOTO?
viral suppression among PLHIV over a 12-month 
period. A total of 596 clients recruited from two 
government HIV treatment facilities in Ziguinchor 
and two in Dakar will be enrolled in the study. Study 
arms (SOC or case management) will be assigned to 
participants through individual randomization at the 
clinic level. 
Data will be periodically collected from study 
participants using questionnaires and biological 
testing. In addition to viral suppression, other 
outcomes to be measured include mental health, 
social support, ART adherence, and stigma. For 
those who received a self-testing kit, the research 
team will inquire about use of the kit, test results, 
acceptability, and feasibility. To assess the cost-
effectiveness of case management, the researchers 
will determine the costs to clients in accessing and 
maintaining participation in the intervention as well 
as the costs to the health system in providing case 
management services. We will analyze the data by 
sex as well as gender identification. 
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Research Utilization 
We will employ a comprehensive research utilization 
strategy to engage stakeholders throughout the 
study design, data collection, results interpretation, 
and findings dissemination processes. Engagement 
with stakeholders aims to ensure local and 
international support of the study, alignment of the 
study with country data needs and priorities, and 
eventual translation of findings into programs and 
policies. 
Our study team consists of JHU, Enda Santé, and 
Senegal MOH investigators to ensure engagement, 
ownership, and utilization of results by all parties. 
We have developed specific indicators for this study 
that will be used to track results uptake. These 
include assessing whether:
	Results are used to guide service delivery in 
Senegal, 
	National policies are changed as noted in the 
Senegalese Country Operational Plan, 
	Stakeholders are engaged throughout the study 
phases, 
	Study aligns with country priorities, and 
	There is community representation in a study 
oversight committee. 
What is case management?
Case management is a multi-step process 
to coordinate care and provide a family-like 
support system for PLHIV. It involves face-to-face 
meetings between the case manager and the 
client, automatic text message sent to the client, 
and phone calls from the case manager. Case 
management approaches help address barriers 
to treatment uptake, adherence, and retention 
by working with individuals to set treatment 
goals, build treatment literacy and self-efficacy 
to execute treatment plans, and provide social 
and logistics support to patients to achieve their 
goals.
How will the HIV self-testing kits be 
used? 
Trained peers will distribute the HIV self-testing 
kits to high-risk and hard-to-reach populations, 
including men who have sex with men, female 
sex workers, and transgender women, to 
facilitate recruitment into the study. The 
trained peers will provide pre-test counseling 
on proper kit use, as well as the importance 
of confirmatory testing, irrespective of an HIV 
positive result. They will emphasize that the kit 
is a screening test and not meant to be used 
as a replacement for HIV testing at a health 
facility. For those who test positive with the HIV 
self-testing kits, there will be a referral to a study 
facility in order to facilitate linkage to care and 
treatment. 
